These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 28338748)
1. Role of scavenger receptors as damage-associated molecular pattern receptors in Toll-like receptor activation. Komai K; Shichita T; Ito M; Kanamori M; Chikuma S; Yoshimura A Int Immunol; 2017 Feb; 29(2):59-70. PubMed ID: 28338748 [TBL] [Abstract][Full Text] [Related]
2. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Yu M; Wang H; Ding A; Golenbock DT; Latz E; Czura CJ; Fenton MJ; Tracey KJ; Yang H Shock; 2006 Aug; 26(2):174-9. PubMed ID: 16878026 [TBL] [Abstract][Full Text] [Related]
3. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. Bowdish DM; Sakamoto K; Kim MJ; Kroos M; Mukhopadhyay S; Leifer CA; Tryggvason K; Gordon S; Russell DG PLoS Pathog; 2009 Jun; 5(6):e1000474. PubMed ID: 19521507 [TBL] [Abstract][Full Text] [Related]
4. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production. Chen X; Li L; Khan MN; Shi L; Wang Z; Zheng F; Gong F; Fang M Innate Immun; 2016 Nov; 22(8):696-705. PubMed ID: 27670944 [TBL] [Abstract][Full Text] [Related]
5. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products. Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627 [TBL] [Abstract][Full Text] [Related]
6. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice. Chen L; Li J; Ye Z; Sun B; Wang L; Chen Y; Han J; Yu M; Wang Y; Zhou Q; Seidler U; Tian D; Xiao F Front Immunol; 2020; 11():585094. PubMed ID: 33193406 [TBL] [Abstract][Full Text] [Related]
7. High mobility group box 1 protein interacts with multiple Toll-like receptors. Park JS; Gamboni-Robertson F; He Q; Svetkauskaite D; Kim JY; Strassheim D; Sohn JW; Yamada S; Maruyama I; Banerjee A; Ishizaka A; Abraham E Am J Physiol Cell Physiol; 2006 Mar; 290(3):C917-24. PubMed ID: 16267105 [TBL] [Abstract][Full Text] [Related]
8. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Hreggvidsdóttir HS; Lundberg AM; Aveberger AC; Klevenvall L; Andersson U; Harris HE Mol Med; 2012 Mar; 18(1):224-30. PubMed ID: 22076468 [TBL] [Abstract][Full Text] [Related]
9. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4. Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181 [TBL] [Abstract][Full Text] [Related]
10. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4. Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416 [TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway. Good DW; George T; Watts BA Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239 [TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Qiu J; Xu J; Zheng Y; Wei Y; Zhu X; Lo EH; Moskowitz MA; Sims JR Stroke; 2010 Sep; 41(9):2077-82. PubMed ID: 20671243 [TBL] [Abstract][Full Text] [Related]
13. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065 [TBL] [Abstract][Full Text] [Related]
15. High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis. Lin Q; Yang XP; Fang D; Ren X; Zhou H; Fang J; Liu X; Zhou S; Wen F; Yao X; Wang JM; Su SB Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1024-32. PubMed ID: 21372296 [TBL] [Abstract][Full Text] [Related]
16. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640 [TBL] [Abstract][Full Text] [Related]
17. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. van Zoelen MA; Yang H; Florquin S; Meijers JC; Akira S; Arnold B; Nawroth PP; Bierhaus A; Tracey KJ; van der Poll T Shock; 2009 Mar; 31(3):280-4. PubMed ID: 19218854 [TBL] [Abstract][Full Text] [Related]
18. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats. Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Rodriguez Guerrero A; Kobayashi S; Ma WY; Liu SY; Zhu P; Baba H Spine (Phila Pa 1976); 2011 Dec; 36(25):2122-9. PubMed ID: 21343866 [TBL] [Abstract][Full Text] [Related]
19. Tissue damage negatively regulates LPS-induced macrophage necroptosis. Li Z; Scott MJ; Fan EK; Li Y; Liu J; Xiao G; Li S; Billiar TR; Wilson MA; Jiang Y; Fan J Cell Death Differ; 2016 Sep; 23(9):1428-47. PubMed ID: 26943325 [TBL] [Abstract][Full Text] [Related]
20. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products. Mazarati A; Maroso M; Iori V; Vezzani A; Carli M Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]